Official Journal of the Italian Society of Orthopaedics and Traumatology
Table 2 Indications and surgical technique
From: Proximal femoral replacement for non-neoplastic conditions: a systematic review on current outcomes
Study | N | Indication | Surgical technique | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
Fracture, N (%) | Periprosthetic, N (%) | Aseptic loosening, N (%) | Infection, N (%) | Other, N (%) | Implant | Approach | Cemented (%) | Constrained liner, N (%) | ||
Bosquet et al., 1980 [30] | 7 | 0 (0) | 3 (42) | 2 (29) | 0 (0) | 2 (29) | A-O | – | C (100) | – |
Sim and Chao, 1981 [32] | 21 | 7 (33) | 6 (29) | 1 (5) | 0 (0) | 7 (33) | Custom | L | C (100) | – |
Malkani et al., 1995 [16] | 50 | 15 (30) | 3 (6) | 26 (52) | 0 (0) | 6 (12) | Monobloc | L | C (100) | – |
Haentjens et al., 1996 [31] | 19 | 0 (0) | 0 (0) | 19 (100) | 0 (0) | 0 (0) | Protek | PL | C (100) | – |
Klein et al., 2005 [22] | 21 | 0 (0) | 21 (100) | 0 (0) | 0 (0) | 0 (0) | Stryker | L | C (100) | 7 (33) |
Shih et al., 2007 [33] | 12 | 1 (8) | 0 (0) | 3 (25) | 8 (67) | 0 (0) | Custom | P | C (100) | – |
Parvizi et al., 2007 [17] | 48 | 1 (2) | 20 (42) | 0 (0) | 13 (27) | 14 (29) | MRS | L | C (100) | 15 (31) |
Jaiswal et al., 2008 [34] | 27 | 0 (0) | 5 (19) | 22 (81) | 0 (0) | 0 (0) | Stanmore | L | C (100) | – |
Schoenfeld et al., 2008 [35] | 22 | 22 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | Mixture | P | C (100) | – |
Bertani et al., 2009 [36] | 8 | 0 (0) | 1 (12) | 7 (88) | 0 (0) | 0 (0) | JVC-IX | AL | C (100) | – |
Subtotal before 2010 | 235 | 46 (20) | 59 (25) | 80 (34) | 21 (9) | 29 (12) | ||||
Gebert et al., 2010 [37] | 45 | 0 (0) | 9 (20) | 20 (44) | 16 (36) | 0 (0) | MUTARS | – | C (7) | – |
Al-Taki et al., 2011 [10] | 63 | 0 (0) | 27 (43) | 27 (43) | 7 (11) | 2 (3) | MRS/GMRS | AL/PL | C (92) | 23 (36) |
Dean et al., 2012 [38] | 8 | 6 (75) | 0 (0) | 0 (0) | 2 (25) | 0 (0) | METS | – | – | – |
McLean et al., 2012 [20] | 20 | 4 (20) | 9 (45) | 0 (0) | 7 (35) | 0 (0) | GMRS | L | C (100) | 7 (35) |
Colman et al., 2014 [43] | 21 | 0 (0) | 21 (100) | 0 (0) | 0 (0) | 0 (0) | GMRS | L/AL | C (100) | 7 (33) |
Calori et al., 2014 [39] | 21 | 12 (57) | 3 (14) | 6 (29) | 0 (0) | 0 (0) | – | – | – | – |
Patel et al., 2014 [40] | 5 | 5 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | Custom | P | C (100) | – |
Lundh et al., 2014 [23] | 5 | 0 (0) | 5 (100) | 0 (0) | 0 (0) | 0 (0) | METS | P | C (100) | – |
Grammatopoulos et al., 2016 [11] | 80 | 12 (15) | 12 (15) | 6 (7) | 40 (50) | 10 (12) | Stanmore | PL/L | C (100) | 3 (4) |
Viste et al., 2017 [19] | 44 | 0 (0) | 15 (34) | 16 (36) | 12 (28) | 1 (2) | GMRS | L | C (100) | 23 (52) |
Corona et al., 2018 [44] | 14 | 0 (0) | 0 (0) | 0 (0) | 14 (100) | 0 (0) | Mixture | – | C (64) | – |
Khajuria et al., 2018 [45] | 37 | 15 (41) | 8 (22) | 8 (22) | 4 (11) | 2 (5) | METS | P | C (100) | – |
Alvand et al., 2018 [21] | 40 | 0 (0) | 0 (0) | 0 (0) | 40 (100) | 0 (0) | METS | – | C (100) | – |
De Martino et al., 2019 [41] | 41 | 3 (7) | 7 (17) | 14 (34) | 17 (41) | 0 (0) | GMRS | PL | C (90) | – |
Fahad et al., 2019 [42] | 21 | 21 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | – | P/L | C (0) | – |
Dieckmann et al., 2019 [46] | 49 | 0 (0) | 0 (0) | 0 (0) | 49 (100) | 0 (0) | MUTARS | – | C (100) | – |
Fenelon et al., 2020 [18] | 79 | 11 (14) | 50 (63) | 9 (11) | 5 (6) | 4 (5) | GMRS/LPS | P/AL | C (100) | – |
Subtotal since 2010 | 593 | 89 (15) | 166 (28) | 106 (18) | 213 (36) | 19 (3) | ||||
Total | 828 | 135 (16) | 225 (27) | 186 (22) | 234 (28) | 48 (6) | ||||
Range | 5–80 | 0–100% | 0–100% | 0–100% | 0–100% | 0–33% | ||||